PMID: 6539445Jun 1, 1984Paper

Adrenoleukodystrophy: clinical and biochemical manifestations in carriers

Neurology
B P O'NeillL C Marmion

Abstract

We studied 21 women from four definite adrenoleukodystrophy (ALD) kinships . Nine women had a spastic paraparesis, including two with peripheral neuropathy. Fifteen women were assigned heterozygote status based on abnormal very-long-chain fatty acid ( VLCFA ) concentrations in plasma, fibroblasts, or both. These 15 included those with abnormal examinations and all women judged to be carriers by clinical criteria. Some ALD heterozygotes have varying degrees of neurologic disease, usually spastic paraparesis. Carrier detection is possible by determination of VLCFA concentrations in plasma and cultured skin fibroblasts. Any woman at risk in an ALD kinship, and who demonstrates a spastic paraparesis, should be assumed to be a carrier until biochemical testing is obtained. To determine whether a woman is an ALD carrier, measurement of plasma VLCFA levels should be done initially. If this gives normal or equivocal results, VLCFA levels should be measured in cultured skin fibroblasts.

Citations

Aug 30, 1986·Clinica Chimica Acta; International Journal of Clinical Chemistry·H NishioK Sumino
Aug 1, 1997·Pediatric Clinics of North America·M J Petruzzi, D M Green
Aug 15, 2012·Orphanet Journal of Rare Diseases·Marc EngelenBwee Tien Poll-The
Apr 11, 2007·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·Shoji Tsuji
Feb 1, 2014·Brain : a Journal of Neurology·Marc EngelenStephan Kemp
Nov 25, 2011·Molecular Genetics and Metabolism·Parastoo JangoukGerald V Raymond
Jan 5, 2011·American Journal of Medical Genetics. Part a·Louise Lapagesse de Camargo PintoIda Vanessa Doederlein Schwartz
Apr 1, 1996·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·T J O'BrienE Byrne
Jan 1, 1991·Pediatric Neurology·W W Marsh, D L Hurst
Apr 14, 2016·Molecular Genetics and Metabolism·Martin J A SchackmannStephan Kemp
Apr 10, 2012·Biochimica Et Biophysica Acta·Stephan KempPatrick Aubourg
Jun 18, 2016·Nature Reviews. Endocrinology·Stephan KempMarc Engelen
Apr 1, 1987·Annals of Neurology·P R AubourgH W Moser
Aug 1, 1987·Acta Paediatrica Japonica; Overseas Edition·H NishioK Sumino
Dec 1, 1984·Annals of Neurology·H W MoserB P O'Neill
Dec 27, 1996·Annals of the New York Academy of Sciences·P Aubourg, J L Mandel
May 12, 2017·Wiener medizinische Wochenschrift·Bela R TurkAli Fatemi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenoleukodystrophy

Adrenoleukodystrophy (ALD), the most frequent peroxisomal disorder, is an X-linked disorder caused by a defect in the metabolism of long chain fatty acids leading to demyelination, neurodegeneration, and death. Here is the latest research.